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patterns and predictors of co-
morbidities in tuberculosis: A cross-
sectional study in the philippines
Laura V. White1, tansy edwards1,2, nathaniel Lee1,3, Mary c. castro4, naomi R. Saludar5, 
Rugaiya W. calapis6, Benjamin n. faguer  1, nelson Dela fuente7, ferdinand Mayoga8, 
nobuo Saito9, Koya Ariyoshi9, Anna Marie celina G. Garfin  10, Juan A. Solon  4 & 
Sharon e. cox  1,9,11*
Diabetes and undernutrition are common risk factors for tB, associated with poor treatment outcomes 
and exacerbated by tB. We aimed to assess non-communicable multimorbidity (co-occurrence of two or 
more medical conditions) in filipino tB outpatients, focusing on malnutrition and diabetes. in a cross-
sectional study, 637 adults (70% male) from clinics in urban Metro Manila (N = 338) and rural Negros 
occidental (n = 299) were enrolled. Diabetes was defined as HbA1c of ≥6.5% and/or current diabetes 
medication. Study-specific HIV screening was conducted. The prevalence of diabetes was 9.2% (54/589, 
95%CI: 7.0–11.8%) with 52% newly diagnosed. Moderate/severe undernutrition (body mass index 
(BMi) <17 kg/2) was 20.5% (130/634, 95%CI: 17.4–23.9%). Forty percent of participants had at least one 
co-morbidity (diabetes, moderate/severe undernutrition or moderate/severe anaemia (haemoglobin 
<11 g/dL)). HIV infection (24.4%, 74/303) was not associated with other co-morbidities (but high 
refusal in rural clinics). central obesity assessed by waist-to-hip ratio was more strongly associated 
with diabetes (Adjusted odds Ratio (AoR) = 6.16, 95%CI: 3.15–12.0) than BMI. Undernutrition was 
less common in men (AoR = 0.44, 95%CI: 0.28–0.70), and associated with previous history of TB 
(AoR = 1.97, 95%CI: 1.28–3.04) and recent reduced food intake. The prevalence of multimorbidity was 
high demonstrating a significant unmet need. HIV was not a risk factor for increased non-communicable 
multimorbidity.
Tuberculosis (TB) remains a global health burden despite advances in diagnosis and treatment and is the leading 
cause of death from a single infectious agent1. Undernutrition is both a risk factor and a consequence of active 
TB disease and is associated with mortality and adverse outcomes2,3. Diabetes is another known risk factor for 
active TB4 and diabetes increases the risk of death and relapse during TB disease5 whilst TB can also negatively 
affect glycaemic control6 and may cause the development of diabetes, although this may sometimes be a tran-
sient effect6. Thus two conditions, both largely nutritional in origin, present a significant challenge to the End 
TB Strategy targets due to the increasing double burden of under and over nutrition occurring in many high 
burden, low and middle-income countries7,8. For implementation of the END TB strategy, it is recommended 
that “All persons with TB need to be assessed for nutritional status and receive nutritional counselling and care 
according to need” and additionally, “all persons with TB should be screened for diabetes” and, “in addition to 
HIV/AIDS, other co-morbidities and health risks associated with TB require integrated management”9. Both 
diabetes and TB can increase the short and long-term risk of cardiovascular10 and respiratory conditions11 requir-
ing lifelong management to reduce population health and economic impacts and are recognised as priorities 
for cost-effective disease control12,13. As well as increasing the risk of developing active TB disease, untreated 
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co-morbid undernutrition and diabetes may also increase the duration of infectivity and risk of relapse, thus 
contributing to ongoing transmission14. Undernutrition and anaemia during and after treatment are also likely 
to affect quality of life and productivity of TB affected households, contributing to a cycle of poverty and risk of 
catastrophic costs to households; the reduction of which is another goal of the End TB Strategy8. However, there 
are relatively few studies or data specifically documenting the prevalence of these and other co-morbid conditions 
in persons with TB or of the extent of overlap between them; information needed for the planning of services.
The Philippines, located in the Western-Pacific region is one of the WHO high burden countries for TB and 
multi-drug resistant TB (MDR-TB) and has the third highest TB incidence of 554/100,000 occurring in the con-
text of a low HIV prevalence, estimated at 2% of incident TB cases, although HIV testing is low in many areas1. 
The prevalence of chronic energy deficiency (BMI < 18.5 kg/m2) in Filipino adults was 10% in the most recent 
National Nutrition Survey completed in 201415. Nationally, the population attributable risk fraction of undernu-
trition (BMI < 18.5 kg/m2) for TB has been estimated at 30%16. The prevalence of diabetes in the Philippines is 
increasing, with the best estimate from 2008 of 7.2%17.
There are currently very limited data of the prevalence of co-morbidities in Filipino persons with TB dis-
ease. Limited data of diabetes in TB has been identified as a barrier to planning a coordinated response18. The 
Philippine’s Plan of Action to Control Tuberculosis identifies the need to develop guidelines for persons living 
with diabetes as a vulnerable group, including screening for diabetes in TB, but undernutrition is not mentioned 
and no TB programme guidelines for its diagnosis and treatment exist19. In the general population obesity and 
in particular central obesity, are common risk factors for diabetes and are important components of various risk 
scores to detect undiagnosed diabetes. However, the relationship of these in persons with active TB disease is 
likely to differ, due to TB-associated weight loss.
The aim of this cross-sectional study was to provide a quantitative assessment of non-communicable multi-
morbidity (co-occurrence of two or more medical conditions)20 in TB DOTS outpatients in a rural and an urban 
setting in the Philippines, focusing on malnutrition and diabetes and on the degree of overlap between co-morbid 
conditions including HIV infection. The primary objective was to determine the prevalence of moderate or severe 
undernutrition (body mass index, BMI, <17.0 kg/m2) and diabetes (HbA1c ≥ 6.5% or receiving treatment for 
diabetes) among adults, aged 18 years and above enrolled in our participating TB-DOTS sites.
Methods
Study design. A cross-sectional survey of persons enrolled in TB-DOTS clinics (ISRCTN12506117).
Setting. Three TB-DOTS clinics in Metro Manila provided data from an urban setting, including the 
TB-DOTS and programmatic management of drug resistant TB (PMDT) centres at San Lazaro Hospital, an 
infectious disease referral hospital and HIV treatment centre, serving a predominantly poor population. Metro 
Manila is identified as a high HIV category area compared to other areas of the country. Two sites on the island of 
Negros Occidental provided data from a rural setting.
participants. All non-pregnant adults (≥18 years) whose TB-DOTS registration date indicated that TB 
treatment should be ongoing at each study site, were eligible to participate. This included any patients who had 
stopped attending the TB DOTS clinic or visited infrequently. Individuals were approached to participate and 
enrolled at the clinics, or were traced and approached by research nurses in their Barangay (neighbourhood). This 
was done to attempt to locate all those whose treatment was supposed to be ongoing, to minimize selection bias.
outcomes. The primary outcome of interest was co-morbid acute undernutrition (BMI <18.5 kg/m2)21 and 
the secondary outcome was diabetes, defined as HBA1c >6.5% or receiving treatment for diabetes at the time of 
enrolment22. However, analyses of undernutrition focussed on moderate and severe undernutrition (BMI <17 kg/
m2), due to this being a level at which intervention is generally recommended. Other secondary outcomes of 
interest were moderate or severe anaemia (haemoglobin <11 g/dL)23, HIV and reported hypertension.
Data collection. Trained research nurses interviewed participants and completed all study assessments using 
structured questionnaires and extracted information recorded on individuals’ National TB Program treatment 
cards using direct electronic data capture with tablets using Open Data Kit software24. Data were uploaded to 
a secure server daily. Household food security was assessed using the Adapted U.S. Household Food Security 
Survey Module (US HFSSM)25. Research nurses conducted anthropometry, including weight (to the nearest 
0.1 kg; Seca 803 Clara Digital Personal Non-Medical Scale) on a flat surface with the patient standing upright 
and unassisted without shoes. Heights were taken (to nearest 0.5 cm; Seca 216 Mechanical Stadiometer) without 
shoes or socks, with the patient standing unsupported and positioned fully upright with the lower border of the 
left orbit and the upper margin of the external auditory meatus horizontal. Waist and hip circumferences were 
measured (to the nearest 0.5 cm; Seca 201 measuring tape), midway between the uppermost border of the iliac 
crest and lower border of costal margin with tape parallel to the floor26. Fingerprick blood samples were used to 
obtain haemoglobin (HemoCue 301, Ängelholm, Sweden), HbA1C, C-reactive protein (CRP) (Alere Afinion 
AS100 Analyzer) and conduct HIV screening (Standard Diagnostics Bioline HIV-1/2 Ag/Ab Combo Rapid Test 
kits) for those with unknown status and who provided additional consent.
Sample size. Sample sizes were calculated based on formulae to estimate prevalence with precision27. A sam-
ple size of 600 (300 urban, 300 rural participants) was determined to provide 90% power to estimate prevalence 
of undernutrition (BMI < 18.5 kg/m2) within ±6% if the true prevalence was between 40–60%, and to estimate 
the prevalence of diabetes within ±5% if the true prevalence was between 5–15%, or within ±4% if the true 
prevalence was between 5–10%. This sample size was also predicted to provide 90% power to detect an absolute 
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difference of at least 15% in the prevalence of acute undernutrition between urban and rural areas if the preva-
lence in the urban area of Metro Manila was between 30% and 60%.
Statistical methods. Data were analyzed using Stata, version 14.1 (College Station TX: StataCorp LP) and 
R28. Characteristics of those enrolled were summarized overall and by area (Metro Manila (urban) and Negros 
Occidental (rural)). Differences in characteristics between areas were tested with either a Fisher’s exact test, t-test 
or Wilcoxon rank sum test as appropriate for the data type. Prevalence of moderate or severe undernutrition, dia-
betes and moderate or severe anaemia are presented with corresponding 95% CIs overall and by area. Differences 
in prevalence of comorbidities by area were tested with Fisher’s exact tests. The distribution of HbA1c versus BMI 
by previous diagnosis status and by area are shown graphically, with associations between BMI and HbA1c tested 
using Spearman’s correlation coefficient. The extent of overlap between diabetes, moderate or severe undernutri-
tion, moderate or severe anaemia and HIV are illustrated with Venn diagrams.
Associations with outcomes of undernutrition and diabetes were investigated using logistic regression. A mul-
tivariable model was built for each outcome using a forward stepwise approach, including factors associated with 
each outcome in univariable analyses based on a likelihood ratio test (LRT) p < 0.1, with retention and exclusion 
criteria of p < 0.1 from a likelihood ratio test comparing models at each model building step.
ethics. Ethical approval was obtained from the ethical review boards of The London School of Hygiene 
& Tropical Medicine (REF: 11995), The School of Tropical Medicine and Global Health, Nagasaki University 
(14th October 2016) and the Philippines National Ethics Committee (REF: 2016–021-Cox-Malnutrition and 
Tuberculosis) and San Lazaro Hospital, Santa Cruz, Manila, the Philippines (23rd February 2017). Written 
informed consent was obtained from all participants prior to study enrolment and additional written consent was 
obtained for optional HIV screening following Dept of Health procedures. All study procedures were conducted 
in accordance with UK, Japan and Filipino laws and regulations including the Philippines Data Privacy Act.
Results
participants. A total of 637 persons were recruited into the study across the five sites; 338 (53.1%) from 
three urban sites (Metro Manila) and 299 (46.9%) from two rural sites (Table 1) during the period 8th May to 
18th September 2017. This represented 63.4% of those identified from the registers in the rural sites and 73.2% in 
the urban sites. Of those enrolled, 37.9% (240/633) had a history of previous tuberculosis treatment, classified 
as either relapse, treatment after loss to follow-up, treatment failure or previous treatment outcome unknown. 
Thirty-five percent of participants had bacteriological confirmation (220/628) of tuberculosis disease. Compared 
to rural areas, participants in urban areas were notably younger (Fisher’s exact test test p < 0.001, mean age 41 
years vs 50 years), more likely to be unmarried (Fisher’s exact test p < 0.001), more likely to have some level of 
education or training beyond primary education (Fisher’s exact test p < 0.001), not have health insurance (Fisher’s 
exact test p = 0.002), have a longer transportation time to the clinic (Fisher’s exact test p < 0.001), and less likely 
to be current smokers (Fisher’s exact test p < 0.001) or frequent drinkers (Fisher’s exact test p < 0.001). There 
was substantially more food insecurity reported in those enrolled at rural sites (Fisher’s exact test p < 0.001), 
compared to urban along with substantially more reported weight loss in the last 3–6 months (Fisher’s exact test 
p < 0.001) and severe decreases in food intake in the last month (Fisher’s exact test p < 0.001). In urban sites, 
slightly more participants were in the intensive rather than continuation phase of treatment (Fisher’s exact test 
p = 0.068). Only one study site (San Lazaro Hospital) in Metro Manila managed persons with MDR-TB and all 
those registered and alive were enrolled making up 10% of participants in the urban sites. There was no difference 
in the proportion of new cases between the urban and rural sites, but a higher rate of bacteriologically confirmed 
cases in the urban sites (Table 1).
Prevalence of co-morbidities. Amongst 634 individuals with BMI measurements, the prevalence of 
all undernutrition (BMI < 18.5 kg/m2) was 36.6% (95% CI: 32.8–40.5%), with 32.1% (95% CI: 27.2–37.4%) in 
the urban sites compared to 41.6% (95% CI: 36.0–47.4%) in the rural sites (Fisher’s exact test p = 0.017). The 
prevalence of moderate or severe undernutrition (BMI < 17 kg/m2) was 20.5% (95% CI: 17.4–23.9%) and more 
common in rural sites (Table 2, 25% vs 17%, Fisher’s exact test p = 0.014). The prevalence of moderate undernu-
trition (16 kg/m2 < BMI < 17 kg/m2) was 8.7% and the prevalence of severe undernutrition (BMI < 16 kg/m2) was 
11.8%. (Table 2). Overall, 29 (4.6%) participants were overweight (BMI 25–30 kg/m2) and 6 (1.0%) were obese 
(BMI ≥ 30 kg/m2).
The prevalence of diabetes was 9.2% (95% CI: 7.0–11.8%) with 52% previously undiagnosed. The prevalence 
of severe or moderate anaemia was 13.6% (95% CI: 11.0–16.5%). The prevalence of self-reported hypertension 
was 8.6% (95% CI: 6.6–11.1). There was no evidence of a difference in prevalence between rural and urban areas 
for these conditions (Table 2).
In the urban sites (Metro Manila), HIV testing is a routine component of TB DOTS clinic enrolment. Of 
the 90% of urban participants whose HIV status was known, 74/303 (24%) were HIV positive. HIV status was 
unknown for 85% of participants in rural sites due to a low number providing consent for study-specific HIV test-
ing (not a routine part of TB DOTS clinic enrolment), therefore subsequent analysis of data including HIV status 
is reported for urban areas only. Less than 1% of all enrolled participants reported previous doctor-diagnosed 
chronic obstructive lung disease or chronic kidney disease.
Multimorbidity. Approximately 40% of enrolled participants had at least one non-communicable clinical 
condition (moderate or severe undernutrition, diabetes and, or moderate or severe anaemia), as measured in 
584 participants with non-missing data for each condition (Fig. 1, Supplementary Fig. 1). In urban sites 100/323 
participants (31.0%) had at least one of these non-communicable conditions compared to 118/261 (45.2%) in 
rural sites (Fisher’s exact test p < 0.001). In urban sites, limited to those with known HIV status, the prevalence 
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Metro Manila  
region (N = 338)
Negros Occidental 
region (N = 299)
Total  
(N = 637) p-value1
Centre
San Nicolas 108
Pedro Gil 102
San Lazaro Hospital 128
Bago City 222
Valladolid 77
Sex
Female 97 (28.7) 94 (31.4) 191 (30.0) 0.488
Male 241 (71.3) 205 (68.6) 446 (70.0)
Age (years)
18–40 183 (54.1) 89 (29.8) 272 (42.7) <0.001
41–65 127 (37.6) 154 (51.5) 281 (44.1)
>65 28 (8.3) 56 (18.7) 84 (13.2)
Household size mean (SD) 4.7 (3.1) 4.7 (2.2) 4.7 (2.7) 0.972
Marital status
Single 171 (50.6) 87 (29.1) 258 (40.5) <0.001
Married 132 (39.1) 165 (55.2) 297 (46.6)
Divorced/separated 8 (2.4) 6 (2.0) 14 (2.2)
Widowed 27 (8.0) 41 (13.7) 68 (10.7)
Highest level of education obtained
Primary 63 (18.6) 155 (51.8) 218 (34.2) <0.001
Secondary 147 (43.5) 104 (34.8) 251 (39.4)
Tertiary 120 (35.5) 27 (9.0) 147 (23.1)
Vocational 8 (2.4) 13 (4.3) 21 (3.3)
Health insurance2
No 145 (45.7) 98 (33.2) 243 (39.7) 0.002
Yes 172 (54.3) 197 (66.8) 369 (60.3)
Time to health clinic (minutes), median (range) 15 (0–300) 6 (1–120) 10 (0–300) <0.001
Smoking status
No or Ex 304 (89.9) 209 (69.9) 513 (80.5) <0.001
Yes 34 (10.1) 90 (30.1) 124 (19.5)
Alcohol consumption
Daily 25 (7.4) 92 (30.8) 117 (18.4) <0.001
Weekly or monthly 78 (23.1) 61 (20.4) 139 (21.8)
Rarely/Never 235 (69.5) 146 (48.8) 381 (59.8)
Weight change last 3–6 months3
No change 70 (20.8) 32 (10.7) 102 (16.0) <0.001
Increase 73 (21.7) 18 (6.0) 91 (14.3)
Decrease 194 (57.6) 249 (83.3) 443 (69.7)
Food intake last 1 month3
No change 196 (58.2) 43 (14.4) 239 (37.6) <0.001
Increase 66 (19.6) 79 (26.4) 145 (22.8)
Moderate decrease 65 (19.3) 98 (32.8) 163 (25.6)
Severe decrease 10 (3.0) 79 (26.4) 89 (14.0)
Household Food security score
Secure 218 (64.5) 108 (36.1) 326 (51.2) <0.001
Moderate insecurity 69 (20.4) 98 (32.8) 167 (26.2)
Severe insecurity 51 (15.1) 93 (31.1) 144 (22.6)
Multi-drug resistant TB
No 305 (90.2) 299 (100.0) 604 (94.8) <0.001
Yes 33 (9.8) 0 (0) 33 (5.2)
Previous TB4
New case 206 (61.5) 187 (62.8) 393 (62.1) 0.806
Relapse case 129 (38.5) 111 (37.3) 240 (37.9)
Bacteriologically confirmed TB5
No 198 (60.2) 210 (70.2) 408 (65.0) 0.009
Yes 131 (39.8) 89 (29.8) 220 (35.0)
Treatment phase6
Intensive 199 (58.9) 133 (44.5) 332 (52.1) <0.001
Continuation 139 (41.1) 166 (55.5) 305 (47.9)
Table 1. Number of patients per site and characteristics of enrolled TB DOTS patients. Data are n (%) of non-
missing values for each characteristic, unless otherwise indicated as mean (SD) or median (range). 1p-value 
from Fishers exact test for categorical variables, t-test to compare means or Wilcoxon rank sum test to compare 
medians. 221 missing values in Metro Manila region and 4 missing values in Negros Occidental region. 
31 missing value in Metro Manila region. 43 missing value in Metro Manila and 1 missing value in Negros 
Occidental region. 59 missing values in Metro Manila region. 6Intensive treatment phase, unless extended, 
is the first 2 months of the 6 month standard TB-DOTS shorter regimen comprising isoniazid, rifampicin, 
pyrazinamide and ethambutol, followed by continuation phase comprising isoniazid and rifampicin only. The 
intensive phase of the 9/12 months WHO shorter regimen for multi-drug resistant TB is the first 4 months 
(unless extended) comprising kanamycin, moxifloxacin, prothionamide, clofazimine, pyrazinamide and 
high dose isoniazid and ethambutol followed by continuation phase comprising moxifloxacin, clofazimine, 
pyrazinamide and ethambutol only.
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of at least one non-communicable condition was 32.1%. Fewer persons enrolled in urban sites were affected by 
one of the non-communicable conditions but 24.4% (74/303) of participants with known status had HIV-TB 
co-infection, only 8 of whom were newly diagnosed as the result of study screening. The most common combina-
tion of two conditions was undernutrition and anaemia in both the urban sites when limited to those with HIV 
data and in all participants in the rural sites (Supplementary Table 1).
Diabetes in persons with tB disease. Of 54 participants with diabetes, 26 (48%) reported a previous 
diagnosis of diabetes, 18 of whom (69%) reported regular diabetes follow-up visits at a health centre or with a 
doctor, whilst 24/26 (92%) reported currently taking diabetes medication (21 metformin or metformin + insu-
lin). However, amongst those reporting diabetic medication, only 9 (38%) were controlled (HbA1c ≤7.0%) with 
HbA1c ranging to over 14% in those remaining (Fig. 2A). There was some evidence of higher HbA1c values in 
those with newly diagnosed versus previously diagnosed diabetes (median HbA1c in newly diagnosed = 10.5% 
and existing = 8.9%, Wilcoxon rank sum test p = 0.040, Fig. 2A). Although the majority of diabetes cases had 
normal BMI (38/54, 70.4%), or were overweight/obese (8/54, 14.8%), there were three diabetes cases in those 
with a BMI < 17 kg/m2, one of whom had severe undernutrition with a BMI < 16 kg/m2 (Fig. 2A). There was no 
apparent correlation between BMI and HbA1c levels (Fig. 2A–C) in those with previously diagnosed diabetes 
(Spearman p = 0.390), or newly diagnosed diabetes (Spearman p = 0.816). In participants with diabetes, hyper-
tension was the most common second co-morbidity (11/54, 20.4%) with the majority (10/11) reporting current 
anti-hypertensive medication. This pattern of co-morbidity in diabetic participants was also observed when lim-
ited to those in the urban sites with complete data for all conditions including HIV (Supplementary Table 1).
factors associated with undernutrition. In univariable analyses (Table 3), participants were more 
likely to be undernourished if they were female (LRT p = 0.002), single or widowed compared to married (LRT 
p = 0.003), did not have health insurance (LRT p = 0.051), experienced weight loss in the previous 3–6 months 
(LRT p = 0.007), reported a moderate or severe reduction in food intake in the previous month (LRT p < 0.001), 
were classified as a relapse/treatment failure, loss to follow-up or previous treatment outcome unknown (LRT 
p = 0.004), were in the intensive versus continuation phase of TB treatment (LRT p = 0.037), had inflammation 
(CRP ≥ 5 mg/L; LRT p = 0.030), or were enrolled in the rural sites (LRT p = 0.011).
In a final multivariable model (Table 3), reduced food intake reported in the previous month, phase of TB 
treatment, marital status and sex, remained associated with undernutrition after adjustment. After adjustment 
for these four variables, none of; weight change in the previous 3–6 months (LRT p = 0.190), health insurance 
(LRT p = 0.165) or area (LRT p = 0.241) were associated with undernutrition and so were not retained in the final 
model. Differences by area observed in Table 2 were mainly explained by reduced food intake in the previous 
Characteristic Metro Manila Region (N = 338) Negros Occidental Region (N = 299) Total p-value1
Undernutrition2
None or mild 280/336, 83.3% (78.9–87.2%) 224/298, 75.2% (69.9–80.0%) 504/634, 79.5% (76.1–82.6%) 0.014
Moderate or severe 56/336, 16.7% (12.8–21.1%) 74/298, 24.8% (20.0–30.1%) 130/634, 20.5% (17.4–23.9%)
Undernutrition2
None 228/336, 67.9% (62.6–72.8%) 174/298, 58.4% (52.6–64.0%) 402/634, 63.4% (59.5–67.2%) 0.048
Mild 52/336, 15.5% (11.8–19.8%) 50/298, 16.8% (12.7–21.5%) 102/634, 16.1% (13.3–19.2%)
Moderate 22/336, 6.5% (4.1–9.7%) 33/298, 11.1% (7.7–15.2%) 55/634, 8.7% (6.6–11.1%)
Severe 34/336, 10.1% (7.1–13.9%) 41/298, 13.8% (10.1–18.2%) 75/634, 11.8% (9.4–14.6%)
Diabetes3
No 299/325, 92.0% (88.5–94.7%) 236/264, 89.4% (85.0–92.8%) 535/589, 90.8% (88.2–93.0%) 0.316
Yes 26/325, 8.0% (5.3–11.5%) 28/264, 10.6% (7.2–15.0%) 54/589, 9.2% (7.0–11.8%)
Anaemia4
None or mild 297/336, 88.4% (84.5–91.6%) 249/296, 84.1% (79.5–88.1%) 546/632, 86.4% (83.5–89.0%) 0.131
Moderate or severe 39/336, 11.6% (8.4–15.5%) 47/296, 15.9% (11.9–20.5%) 86/632, 13.6% (11.0–16.5%)
HIV5
No 229/303, 75.6% (70.3–80.3%) 39/41 –
Yes 74/303, 24.4% (19.7–29.7%) 2/41
Reported hypertension
No 312/338, 92.3% (88.9–94.9%) 270/299, 90.3% (86.4–93.4%) 582/637, 91.4% (88.9–93.4%) 0.398
Yes 26/338, 7.7% (5.1–11.1%) 29/299, 9.7% (6.6–13.6%) 55/637, 8.6% (6.6–11.1%)
Reported chronic obstructive 
pulmonary disease
No 338/338, 100.0% (98.9–100.0%) 296/299, 99.0% (97.1–99.8%) 634/637, 99.5% (98.6–99.9%) 0.103
Yes 0/338, 0.0% (0.0–1.1%) 3/299, 1.0% (0.2–2.9%) 3/637, 0.5% (0.1–1.4%)
Reported Chronic kidney 
disease
No 336/338, 99.4% (97.9–99.9%) 298/299, 99.7% (98.2–100.0%) 634/637, 99.5% (98.6–99.9%) 1.000
Yes 2/338, 0.6% (0.1–2.1%) 1/299, 0.3% (0.0–1.8%) 3/637, 0.5% (0.1–1.4%)
Inflammatory status (CRP)6
<5 mg/l 290/318, 91.2% (87.5–94.1%) 213/227, 93.8% (89.9–96.6%) 503/545, 92.3% (89.7–94.4%) 0.328
≥5 mg/l 28/318, 8.8% (5.9–12.5%) 14/227, 6.2% (3.4–10.1%) 42/545, 7.7% (5.6–10.3%)
Table 2. Prevalence of co-morbidities amongst enrolled TB DOTS patients. 1p-value from Fishers exact test 
for categorical variables. 22 missing values in Metro Manila region and 1 missing value in Negros Occidental 
region. Undernutrition is defined using BMI kg/m2: mild: <18.5–17; moderate: <17–16; severe: <16; none: 
≥18.5. 313 missing values in Metro Manila region and 35 missing values in Negros Occidental region. Diabetes 
defined as HbA1c ≥ 6–5% or on current diabetes medication. 42 missing values in Metro Manila region and 3 
missing values in Negros Occidental region. Moderate or Severe anaemia defined as haemoglobin<10 g/dL. 
5only 41/299 patients were tested for HIV in Negros Occidental region, 35 missing values in Metro Manila. 
6C-REactive Protein; Ref. 45.
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month being more common in the rural sites. In a reduced dataset due to missing data, inflammation was not 
associated (LRT p = 0.129) with undernutrition after adjustment for food intake in the previous month, phase 
of TB treatment, marital status and sex. There was no evidence of interaction between sex and any of the other 
covariates in the final model (LRT p > 0.1). Fitting the final model in just the urban sites where HIV was tested 
and those with MDR-TB were enrolled, there was no evidence of increased odds of undernutrition in HIV posi-
tive versus negative participants (adjusted odds ratio, AOR = 0.54; 95% CI: 0.22–1.34, LRT p = 0.177), or in those 
with MDR-TB versus drug sensitive TB (AOR = 1.66, 95% CI: 0.69–4.01, LRT p = 0.274).
Undernutrition and anaemia in persons with drug sensitive TB. Although the prevalence of mod-
erate/severe undernutrition was lower in persons in the continuation phase compared to intensive phase of TB 
treatment (Table 3), a relatively high prevalence was still observed in persons nearing completion of their DS-TB 
treatment in the 5th or 6th month at 13.9% (26/187). Similarly, the prevalence of moderate and severe anaemia 
was also lower in persons in continuation compared to intensive phase of treatment (9.6% vs. 17.3% Fisher’s exact 
test p = 0.005). However, in months 5 or 6 of drug sensitive treatment when TB/inflammatory associated anaemia 
is expected to have resolved it was observed that of 186 participants: 29 (15.6%) had mild, 14 (7.5%) moderate 
and 2 (1.1%) had severe anaemia. Of 15 cases of moderate/severe anaemia in month 5 or more of treatment and 
with CRP measurements, only 3 (20%) had inflammation (CRP > 5 mg/L). Thus, anaemia in the final months of 
treatment did not appear to be fully explained by remaining inflammation, suggesting a role for iron deficiency 
in these cases of anaemia.
factors associated with diabetes. In univariable analyses, increasing age (LRT p < 0.001), having health 
insurance (LRT p = 0.051), being married or widowed rather than being single (LRT p = 0.003), and central 
obesity (waist-to-hip ratio >0.9 for men and >0.85 for women26) (LRT p < 0.001) were associated with having 
existing or newly diagnosed diabetes (Table 4). BMI categorization into normal, underweight, overweight or 
obese was associated with odds of diabetes (LRT p < 0.001), mostly due to the odds of diabetes being much lower 
in those who were undernourished compared to those with normal weight. Few participants were overweight 
or obese (n = 34) and whilst odds of diabetes were higher than for those with normal weight, these did not 
reach statistical significance. Marital status was no longer associated with diabetes after adjustment for age (LRT 
p = 0.680) and the final multivariable model included age group, health insurance and central obesity based on 
waist-to-hip ratio (Table 4). Fitting the final model in just the urban sites including HIV status and participants 
with MDR-TB were enrolled, there was no evidence of increased odds of diabetes in HIV positive versus negative 
persons (AOR = 0.21, 95% CI: 0.02–1.98, LRT p = 0.126), or in those with MDR-TB versus drug sensitive TB 
(AOR = 2.91, 95% CI: 0.85–10.0, LRT p = 0.103).
Given the strong association between central obesity based on waist-to-hip ratio cut-off value of >0.85 
for women and >0.9 for men, an analysis was conducted to assess the sensitivity and specificity of different 
waist-to-hip ratio thresholds to correspond to diabetes. Thresholds were considered within a range of 0.7–1.1 in 
increments of 0.05. Results of these simple, unadjusted analyses suggest a threshold of >0.85 for persons of both 
sexes in this study would have sensitivity of 87% (95% CI: 0.75–95%) and specificity of 54% (95% CI: 50–58%, 
Supplementary Table 2).
Discussion
The aim of this cross-sectional study was to evaluate the burden and predictors of diabetes, undernutrition and 
anaemia co-morbidities in TB DOTS outpatients in a rural and an urban setting in the Philippines and to describe 
co-morbidity inter-relationships including with HIV-infection. To our knowledge, this study provides the first 
published estimates of the prevalence of malnutrition and diabetes among persons receiving anti-TB treatment 
(ATT) in routine outpatient TB-DOTs clinics in the Philippines. The prevalence of diabetes, at 9.1%, with more 
than 50% of diabetes cases newly diagnosed by the study screening was higher than current national estimates 
for the Philippines general population (6.1%,WHO 2016)29. but lower than the 14.1% reported in 634 urban 
HIV-negative Indonesians with newly diagnosed pulmonary TB, systematically assessed for diabetes by fast-
ing blood glucose30 and more recently of 19.7% in the Indonesian participants of the multi-country “TANDEM 
study”31. Previous limited reports in the Philippines include a diabetes prevalence of 18% in pulmonary TB 
patients in Quezon City (N = 38)32, and 17.7% in a cohort of acutely unwell admissions to a TB ward in Manila 
(N = 348)33.
Undernutrition (BMI < 18.5 kg/m2) was the most common comorbidity affecting just over a third of all par-
ticipants and was more common in the rural sites where greater household food insecurity, decreased food intake 
and recent weight loss were also reported. There was relatively little clustering of multimorbidity within individ-
uals, with surprisingly little overlap between moderate/severe undernutrition and moderate/severe anaemia or 
between HIV and non-communicable conditions, for which HIV is a known risk factor. On further exploration, 
the participants in urban areas living with HIV were younger than those without HIV (31.7 vs 44.4 years) and 
only 2 were new diagnoses not already enrolled in HIV care programmes, which may explain these observations.
The high prevalence of moderate and severe undernutrition, including in the final months of treatment, when 
possible TB-mediated catabolic effects should have resolved, combined with frequent household food insecu-
rity, indicate an important unmet need for nutritional support in persons with TB. Similar findings have been 
reported in a rural TB cohort in India, but at a higher prevalence and degree of severity, with 47% of males and 
62% of females being severely undernourished (BMI < 16 kg/m2) at the start of treatment and 17% of males and 
35% of females at treatment completion. The prevalence of severe anaemia (haemoglobin <8 g/dL) at start of 
treatment was 20%, whilst diabetes was reported in 11%. HIV prevalence was 4.4%. Unfortunately, this study did 
not report the proportions of participants with multiple co-morbidities34. The WHO guideline on Nutritional 
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care and support for patients with tuberculosis states that “because of the clear bidirectional causal link between 
undernutrition and active TB, nutrition screening, assessment and management are integral components of TB 
treatment and care”35. These study results can be utilized in the Philippines to inform planning of TB treatment 
and care related to undernutrition, in which currently height is not assessed to allow calculation of BMI and 
no anaemia screening occurs. Many countries offer cash transfers or some kind of nutritional support to those 
undergoing treatment for MDR-TB, but do not extend this to drug sensitive TB (including the Philippines). 
Participants with a previous history of TB were almost twice as likely to be undernourished, indicating a probable 
downward spiral effect of undernutrition and TB. Thus, not addressing undernutrition during TB treatment may 
be contributing to the high rates of TB recurrence (38% of participants reported previous TB disease and were 
classified as relapse, treatment failure, loss to follow-up or previous treatment unknown). It remains to be deter-
mined if effectively treating undernutrition during an initial TB treatment can reduce risk of TB recurrence and 
thus be a cost-effective intervention. In this outpatient population, men had a lower risk of undernutrition than 
women. This is in contrast to our observation in a Filipino inpatient cohort (also 70% male) in whom there was 
no difference in the prevalence of moderate/severe undernutrition by sex, but in whom there was a statistically 
significant difference in the risk of inpatient death between male and female undernourished patients, with a 
greater risk in men33.
Poor glucose control is associated with poorer treatment outcomes36–38 (reviewed in39), and increased risk of 
developing diabetes associated complications and recurrent TB40. Although there is currently limited direct evi-
dence that improved glucose control improves TB treatment outcomes, the high prevalence of poorly controlled 
blood glucose; even when using the more realistic target of HbA1c% <8%40, and including in those reporting to 
be on regular diabetes medication is worrying. The data suggests that both tuberculosis and non-communicable 
disease programmes have a large task of ensuring glycemic control among their program clients. The risk of dia-
betes was the greatest in the middle-aged group (40–65 years). However, unlike recent data from a multi-country 
study investigating diabetes in TB (the TANDEM study), we did not observe an association between diabetes and 
previous TB or with smear positive cases31. The distribution of HbA1c values for our diabetic population (new 
and previously diagnosed cases) was also similar to that from the Indonesian TANDEM study population, in 
whom a single point of care (POC) HbA1c test was shown to have high sensitivity and specificity to detect new 
diabetes cases, adding confidence to our diagnoses of diabetes using this single POC measurement41.
Our data demonstrate that diabetes whether previously or newly diagnosed was not limited to those with 
higher BMI, and could also occur in those with severe or moderate undernutrition. In multivariable analysis, 
Figure 1. Percentage of persons with TB with co-morbidities1 overall and by area1 amongst participants with 
non-missing values for each comorbidity shown.
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waist to hip ratio was strongly associated with diabetes, whilst BMI was not significant. We thus investigated how, 
in resource-limited settings, waist-to-hip ratio might be useful as a screening tool for prioritising individuals for 
diabetes testing and observed a high sensitivity of 87% for a single cut-off for both sexes, supporting its potential 
use, at least in the Filipino context. Mean waist to hip ratio was also significantly increased in the TANDEM study, 
and most significantly in Indonesia31, although neither waist to hip ratio or waist circumference were included in 
the final multicountry predictive risk score for diabetes in persons with TB41.
TB programmes, in which individuals are in regular contact with local health services, provide an opportunity 
to increase rates of diabetes diagnosis (and other important NCD conditions like hypertension), and to re-engage 
with persons with diabetes who may have dropped out of diabetes care. Although there is still limited evidence 
to support how persons with TB-diabetes should be managed and how integration of services can be achieved, 
specific guidelines on management have recently been released based on best available evidence and expert opin-
ion42. Diabetes management should include drug management, nutritional status assessment, dietary and lifestyle 
counselling (healthy diet, weight management, physical activity, smoking cessation and avoiding excess alcohol), 
which are also recommended as part of routine TB care. Training of TB health workers in diagnosing and man-
aging diabetes, undernutrition and anaemia would provide a more holistic and patient-centered approach to TB 
Figure 2. HbA1c by body mass index in new and previously diagnosed diabetes cases, overall and by urban/
rural area.
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management and hopefully avoid conflicting advice being given. Integration of services, which are currently split 
between infectious and non-infectious, will present significant challenges but also opportunities for leveraging of 
resources and investments between domestic and international funding sources.
This study did not rely on routine testing or self-reporting of diabetes or undernutrition and used trained 
research nurses to conduct all assessments and anthropometry. Although the use of a single POC test for HbA1c is 
not currently recommended for diabetes diagnosis by regulatory bodies, its agreement with accredited laboratory 
measurement using high performance liquid chromatography in persons with TB has recently been shown to be 
high, with minimal effects on clinical misclassification43. However, the higher proportion of participants with severe 
anaemia in our setting may have resulted in some misclassification in this group. It has been reported that severe 
anaemia can affect HbA1c, with possible over-estimation in iron deficiency anaemia and under-estimation with 
haemolytic anaemia44. In the small number of those with severe anaemia in the study comparing POC HbA1c with 
laboratory HbA1c, the POC test showed a mean difference of +1.1%43. The amount of missing information for HIV 
Characteristic N
Undernourished, 
n (%)
Unadjusted OR 
(95% CI) p-value1
Adjusted OR2 
(95% CI) p-value1
Sex
Female 190 54 (28.4) 1 0.002 1 0.001
Male 444 76 (17.1) 0.52 (0.35df0.78) 0.44 (0.28–0.70)
Age category (years)
18–40 271 47 (17.3) 1 0.216 —
41–65 279 65 (23.3) 1.45 (0.95–2.20) —
>65 84 18 (21.4) 1.30 (0.71–2.39) —
Family size 634 0.96 (0.89–1.03) 0.282 —
Marital status
Married 295 45 (15.3) 1 0.003 1 0.001
Single 257 63 (24.5) 1.80 (1.18–2.76) 2.30 (1.44–3.67)
Divorced/separated 14 1 (7.1) 0.43 (0.05–3.35) 0.61 (0.07–4.95)
Widowed 68 21 (30.9) 2.48 (1.36–4.54) 2.29 (1.18–4.46)
Highest level of 
education obtained
Primary 218 48 (22.0) 1 0.684 —
Secondary 249 53 (21.3) 0.96 (0.62–1.49) —
Tertiary 146 25 (17.1) 0.73 (0.43–1.25) —
Vocational 21 4 (19.0) 0.83 (0.27–2.59) —
Health insurance
No 242 60 (24.8) 1 0.051 —
Yes 368 67 (18.2) 0.68 (0.46–1.00) —
Time to health clinic (minutes) 634 1.00 (0.99–1.00) 0.281 —
Smoking status
No or Ex 510 110 (21.6) 1 0.169 —
Yes 124 20 (16.1) 0.70 (0.41–1.18) —
Alcohol consumption
Daily 117 28 (23.9) 1 0.503 —
Weekly or monthly 139 25 (18.0) 0.70 (0.38–1.28) —
Rarely/Never 378 77 (20.4) 0.81 (0.50–1.33) —
Weight change last 3–6 
months
No change 102 16 (15.7) 1 0.007 —
Increase 91 10 (11.0) 0.66 (0.28–1.55) —
Decrease 441 104 (23.6) 1.66 (0.93–2.95) —
Food intake last 1 month
No change 238 33 (13.9) 1 <0.001 1 <0.001
Increase 145 24 (16.6) 1.23 (0.70–2.18) 1.47 (0.79–2.72)
Moderate decrease 163 42 (25.8) 2.16 (1.30–3.58) 2.41 (1.39–4.17)
Severe decrease 88 31 (35.2) 3.38 (1.91–5.98) 4.48 (2.40–8.37)
Household Food 
security
Secure 324 57 (17.6) 1 0.147 —
Moderate insecurity 167 37 (22.2) 1.33 (0.84–2.12) —
Severe insecurity 143 36 (25.2) 1.58 (0.98–2.53) —
TB treatment phase1
Intensive 329 78 (23.7) 1 0.037 —
Continuation 305 52 (17.0) 0.66 (0.45–0.98) —
Previous TB
New case 393 67 (17.1) 1 0.005 1 0.002
Relapse case 237 63 (26.6) 1.76 (1.19–2.60) 1.97 (1.28–3.04)
Bacteriologically 
confirmed TB
No 407 74 (18.2) 1 0.072 1 0.050
Yes 218 53 (24.3) 1.45 (0.97–2.15) 1.56 (1.00–2.42)
Inflammatory status 
(CRP)3
<5 mg/l 502 96 (19.1) 1 0.030 —
≥5 mg/l 41 14 (34.2) 2.19 (1.11–4.34) —
Area
Urban 336 56 (16.7) 1 0.011 —
Rural 298 74 (24.8) 1.65 (1.12–2.44) —
Table 3. Univariable and multivariable analysis of factors associated with undernutrition. OR = odds ratio, 
CI = confidence interval. 1p-value from likelihood ratio test. 2Adjusted ORs shown for covariates retained in the 
final multivariable model (if effects are not reported, covariate was not included). 3C-reactive protein Ref. 45.
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status is a limitation, especially for the rural sites. HIV in TB in the Philippines is still low at 2%1. The prevalence 
reported in the urban sites of this study is not representative of the majority of Filipino persons with TB due to 
the inclusion of a hospital site which is one of the largest HIV referral sites in the city. This can be seen as another 
Characteristic N
Type 2  
diabetes, n (%)
Unadjusted OR 
(95% CI) p-value1
Adjusted OR2 
(95% CI) p-value1
Sex
Female 173 17 (9.8) 1 0.723 —
Male 416 37 (8.9) 0.90 (0.49–1.64) —
Age category (years)
18–40 256 6 (2.3) 1 <0.001 1 <0.001
41–65 258 41 (15.9) 7.87 (3.28–18.9) 5.93 (2.41–14.6)
>65 75 7 (9.3) 4.29 (1.40–13.2) 3.07 (0.97–9.70)
Family size 589 0.93 (0.83–1.05) 0.219 —
Marital status
Single 243 10 (4.1) 1 0.003 —
Married 273 36 (13.2) 3.54 (1.72–7.30) —
Divorced/separated 11 1 (9.1) 2.33 (0.27–20.0) —
Widowed 62 7 (11.3) 2.97 (1.08–8.14) —
Highest level of education 
obtained
Primary 197 16 (8.1) 1 0.221 —
Secondary 231 28 (12.1) 1.56 (0.82–2.98) —
Tertiary 142 9 (6.3) 0.77 (0.33–1.79) —
Vocational 19 1 (5.3) 0.63 (0.08–5.02) —
Health insurance
No 226 14 (6.2) 1 0.051 1 0.032
Yes 350 38 (10.9) 1.84 (0.98–3.49) 2.05 (1.05–4.05)
Time to health clinic (minutes) 589 0.99 (0.98–1.00) 0.128 —
Smoking status
No or Ex 476 44 (9.2) 1 0.896 —
Yes 113 10 (8.8) 0.95 (0.46–1.96) —
Alcohol consumption
Daily 111 12 (10.8) 1 0.783 —
Weekly or monthly 133 11 (8.3) 0.74 (0.31–1.76) —
Rarely/Never 345 31 (9.0) 0.81 (0.40–1.65) —
Weight change last 3–6 
months
No change 97 8 (8.2) 1 0.730 —
Increase 82 6 (7.3) 0.88 (0.29–2.64) —
Decrease 410 40 (9.8) 1.20 (0.54–2.66) —
Food intake last 1 month
No change 223 18 (8.1) 1 0.553 —
Increase 136 10 (7.4) 0.90 (0.40–2.02) —
Moderate decrease 152 17 (11.2) 1.43 (0.71–2.88) —
Severe decrease 78 9 (11.5) 1.49 (0.64–3.46) —
Food security
Secure 308 30 (9.7) 1 0.689 —
Moderate insecurity 148 11 (7.4) 0.74 (0.36–1.53) —
Severe insecurity 133 13 (9.8) 1.00 (0.51–1.99) —
TB treatment phase
Intensive 307 32 (10.4) 1 0.269 —
Continuation 282 22 (7.8) 0.73 (0.41–1.28) —
Previous TB
New case 366 31 (8.5) 1 0.523 —
Relapse case 219 22 (10.1) 1.21 (0.68–2.14) —
Bacteriologically confirmed 
TB
No 373 29 (7.8) 1 0.136 —
Yes 208 24 (11.5) 1.55 (0.88–2.74) —
Inflammatory status (CRP)
<5 g/l 502 44 (8.8) 1 0.121 —
≥5 g/l 42 7 (16.7) 2.08 (0.87–4.96) —
BMI group3
Normal 216 8 (3.7) 1 <0.001 —
Underweight 337 38 (11.3) 0.30 (0.14–0.66) —
Overweight 28 6 (21.4) 2.15 (0.82–5.63) —
Obese 6 2 (33.3) 3.93 (0.70–22.2) —
Central obesity: waist-to-
hip ratio4
No 393 13 (3.3) 1 <0.001 1 <0.001
Yes 195 41(21.0) 7.78 (4.06–14.9) 6.16 (3.15–12.0)
Area
Urban 325 26 (8.0) 1 0.277 —
Rural 264 28 (10.6) 1.36 (0.78–2.39) —
Table 4. Univariable and multivariable analysis of factors associated with Type 2 diabetes. OR = odds ratio, CI 
= confidence interval. 1p-value from likelihood ratio test. 2Adjusted ORs shown for covariates retained in the 
final multivariable model (if effects are not reported, covariate was not included). 3underweight: Body Mass 
Index underweight: <18.5, normal: 18.5–24.9, overweight: 25.0–29.9, obese ≥30 kg/m2. 4based on waist-to-hip 
ratio >0.85 for women and >0.9 for men.
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limitation, but also allowed us, with a reasonable study sample size, to explore the effect of HIV on the frequency and 
overlap of our other clinical conditions of interest. Finally, hypertension was not directly assessed but was based on 
patient report. Our diabetes prevalence estimate could be overestimated due to TB induced transient hyperglycemia, 
greater in the early phase of treatment; or underestimated if those with diabetes were less likely to be included due 
to more frequent poor TB treatment outcomes, or were of higher social status and less likely to be treated for TB in 
public facilities. The cross-sectional study design thus limits the conclusions that can be drawn regarding possible 
causality between changes in the prevalence of co-morbid conditions over TB treatment duration.
Future studies should directly assess hypertension, other respiratory conditions and diabetes associated 
co-morbidities such as peripheral neuropathy, retinopathy, kidney function and blood lipids to further inform 
specific management strategies and resources for diabetes in management in TB programmes. The evidence base 
also requires further strengthening, in relation to context-specific dietary management strategies, especially of 
diabetes in those who are also undernourished, and of the effects of nutritional supplementation on TB, multi-
morbidity and long-term health sequalae of TB.
conclusions
This study provides evidence of a high burden of co-morbidities in Filipino persons with drug-sensitive TB, 
including in rural areas. In this study, multimorbidity was not a problem limited to those with HIV co-infection. 
Moderate and severe undernutrition and anaemia were also observed in the final months of TB treatment indicat-
ing the need for additional interventions to detect and treat these conditions. Our findings are likely applicable to 
other country settings with a double burden of under-and overnutrition and low HIV. For effective management 
of multimorbidity, health care programmes need to move towards integration of services and include support for 
nutrition and lifestyle management.
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